← Back to all earnings calls

Sutro Biopharma, Inc. Q2 FY2024 Earnings Call

Sutro Biopharma, Inc. (STRO)

Earnings Call FY2024 Q2 Call date: 2024-08-13 Concluded

Share

Quarter scorecard

Revenue

$25.71M

+146.9% YoY

Diluted EPS

$-5.90

Net income

-$48.02M

Documents & deck